Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1580822

registered interest
date	25/01/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has received evidence from the life sciences industry of the impact on UK R&D investment and potential increases in payment rates under the voluntary and statutory schemes for branded medicines; and if it will make a statement.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	132374
answer	answer is ministerial correction date of answer 01/02/2023 answer text <p>The Department has been consulting on a proposed update to the <ins class="ministerial">s</ins><del class="ministerial">S</del>tatutory <ins class="ministerial">s</ins><del class="ministerial">S</del>cheme for branded medicines and the life sciences industry has been able to <ins class="ministerial">give evidence</ins><del class="ministerial">express its views</del> as part of this consultation process.</p><p><del class="ministerial">In considering the responses, the Department is carefully taking into account any evidence submitted on potential impacts for the United Kingdom life sciences sector.</del></p><p>The Government remains firmly committed to the <ins class="ministerial">s</ins><del class="ministerial">S</del>tatutory and <ins class="ministerial">v</ins><del class="ministerial">V</del>oluntary schemes for branded medicines and to working with the pharmaceutical industry to deliver on the ambitions set out in the Life Sciences Vision to create an environment that facilitates innovation for the development of medicines in the UK.</p> answering member constituency Colchester answering member printed Will Quince question first answered 01/02/2023 11:22:27 question first ministerially corrected 01/02/2023 11:38:17 answering member 4423 label Biography information for Will Quince previous answer version 51971 answering member constituency Colchester answering member printed Will Quince answering member 4423 label Biography information for Will Quince
tabling member	4092 label Biography information for Stephen Metcalfe

1580823

registered interest
date	25/01/2023
answering body	Department for Business, Energy and Industrial Strategy
answering dept id	201
answering dept short name	Business, Energy and Industrial Strategy
answering dept sort name	Business, Energy and Industrial Strategy
hansard heading	Voluntary Scheme for Branded Medicines Pricing and Access
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, whether his Department has made an assessment of a potential link between (a) the rebate in the Voluntary Scheme for Branded Medicines Pricing and Access and (b) the accompanying Statutory Scheme on the level of foreign direct investment into UK R&D.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	132375
answer	answer is ministerial correction date of answer 02/02/2023 answer text <p>The Government is working to better understand the impacts the operation of the current Voluntary Scheme and the accompanying Statutory Scheme on investments in the UK. We are therefore in direct conversations with companies to understand these impacts. The Department for Business, Energy and Industrial Strategy is in close discussions with the Department of Health and Social Care, the Department responsible for the Voluntary Scheme and Statutory Scheme, about the business environment for life sciences and its impact on investment.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 02/02/2023 16:45:03 answering member 4020 label Biography information for George Freeman
tabling member	4092 label Biography information for Stephen Metcalfe

1458180

registered interest
date	19/04/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support research into intra-nasal covid-19 vaccines.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	906532
answer	answer is ministerial correction date of answer 19/04/2022 answer text <p>The Department of Health and Social Care commissions research through the National Institute for Health and Care Research (NIHR) which, with UK Research and Innovation, has co-funded an Imperial College London study worth £580,000 looking specifically at the safety and effectiveness of two COVID-19 vaccines administered via the respiratory tract.</p><p>The study is ongoing but in later stages and results will be made public in due course and following peer review.</p><p>The NIHR is also providing infrastructure support to an Oxford University study looking at safety and effectiveness of intranasal administration of the Oxford/AstraZeneca vaccine.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 19/04/2022 16:20:30 answering member 4447 label Biography information for Maggie Throup
tabling member	4092 label Biography information for Stephen Metcalfe

1453317

registered interest
date	22/03/2022
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Electric Vehicles: Charging Points
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, if he will make an assessment of the compatibility of differing VAT rates for public and domestic charging of electric vehicles with the principle of VAT neutrality.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	144894
answer	answer is ministerial correction date of answer 29/03/2022 answer text <p>In order to keep costs down for families, the supply of electricity for domestic use attracts the reduced rate of VAT (five per cent).</p><p> </p><p>Electricity supplied at EV charging points in public places is subject to the standard rate of VAT (twenty per cent). The Government has not specifically introduced a reduced rate for charging EVs at home. However, the practical challenges of differentiating between the electricity used at home for general domestic purposes, and electricity used to charge EVs currently mean that the reduced rate is effectively being applied to EV home-charging.</p><p> </p><p>Applying the reduced rate of VAT to electricity supplied at EV charging points in public places would come at a cost. VAT makes a significant contribution towards the public finances, raising around £130 billion in 2019/20, and helps fund the Government's priorities including the NHS, schools, and defence. Any loss in tax revenue would have to be balanced by a reduction in public spending, increased borrowing or increased taxation elsewhere.</p><p> </p><p>The Government has no current plans to review the current rate of VAT applied to EV charging.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 29/03/2022 10:31:10 answering member 4527 label Biography information for Helen Whately
tabling member	4092 label Biography information for Stephen Metcalfe

1453318

registered interest
date	22/03/2022
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Electric Vehicles: Charging Points
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, with reference to Value Added Tax Act 1994 Schedule 7A, Group 1, Paragraph 5, on what basis some electric vehicle charging is taxed at a rate of 20 per cent VAT.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	144895
answer	answer is ministerial correction date of answer 29/03/2022 answer text <p>The domestic use of fuel (including electricity that may be used to recharge vehicles) is subject to the reduced rate of VAT of 5%. As set out in Paragraph 5 of Schedule 1, where a supply to a person at their premises does not exceed 1000 kilowatt hours per month, this is deemed to be domestic use.</p><p> </p><p>However, for this provision to apply, the supply of electricity must be to a customer’s house or building. Where this is not the case (such as where a vehicle is recharged at a public charge point), the electricity is standard rated.</p><p> </p><p> </p><p>Further clarification can be found in HM Revenue and Customs Brief 7 (2021): VAT liability of charging of electric vehicles.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 29/03/2022 15:33:01 answering member 4527 label Biography information for Helen Whately
tabling member	4092 label Biography information for Stephen Metcalfe

1421352

registered interest
date	09/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of when his Department will receive the report and recommendations of the UK National Screening Committee on a national lung screening programme.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	121744
answer	answer is ministerial correction date of answer 21/02/2022 answer text <p>The UK National Screening Committee (UK NSC) plans to open a three-month public consultation on the evidence for lung cancer screening in the coming weeks.</p><p>The Department will receive the UK NSC’s recommendation on lung cancer screening in individuals at an increased risk following its June meeting.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 21/02/2022 09:21:10 answering member 4492 label Biography information for Maria Caulfield
tabling member	4092 label Biography information for Stephen Metcalfe

1421353

registered interest
date	09/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to page 15 of NHS England’s 2022-23 priorities and operational planning guidance, whether NHS England plans to publish details of the Targeted Lung Health Check projects that will be launched in 202-23.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	121745
answer	answer is ministerial correction date of answer 21/02/2022 answer text <p>Up to £70 million of targeted funding under the National Health Service Cancer Programme’s Service Development Funding budget has been made available to support the running of Targeted Lung Health Checks (TLHC) in 2022/23. This will include the expansion of the programme to ensure a project in each Cancer Alliance.</p><p>NHS England and NHS Improvement also supports the delivery of the TLHC programme with standard protocols, expert advice, and nationally procured and coordinated quality assurance and training.</p><p>There are currently nine Cancer Alliances without a TLHC project. NHS England and NHS Improvement plan to expand the TLHC programme in 2022/23 to ensure that each of these Cancer Alliances has at least one TLHC programme. We estimate an additional eight computerised tomography (CT) scanners will be needed to facilitate this expansion.</p><p> </p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 121746 121747 question first answered 21/02/2022 09:10:42 answering member 4492 label Biography information for Maria Caulfield
tabling member	4092 label Biography information for Stephen Metcalfe

1421355

registered interest
date	09/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what (a) funding and (b) additional support NHS England has made available to Cancer Alliances to ensure each operates at least one targeted lung health check project from 2022-23.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	121746
answer	answer is ministerial correction date of answer 21/02/2022 answer text <p>Up to £70 million of targeted funding under the National Health Service Cancer Programme’s Service Development Funding budget has been made available to support the running of Targeted Lung Health Checks (TLHC) in 2022/23. This will include the expansion of the programme to ensure a project in each Cancer Alliance.</p><p>NHS England and NHS Improvement also supports the delivery of the TLHC programme with standard protocols, expert advice, and nationally procured and coordinated quality assurance and training.</p><p>There are currently nine Cancer Alliances without a TLHC project. NHS England and NHS Improvement plan to expand the TLHC programme in 2022/23 to ensure that each of these Cancer Alliances has at least one TLHC programme. We estimate an additional eight computerised tomography (CT) scanners will be needed to facilitate this expansion.</p><p> </p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 121745 121747 question first answered 21/02/2022 09:10:42 answering member 4492 label Biography information for Maria Caulfield
tabling member	4092 label Biography information for Stephen Metcalfe

1421356

registered interest
date	09/02/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lung Diseases: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the increase in CT scanner numbers required to ensure each Cancer Alliance operates at least one targeted lung health check from 2022-23.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	121747
answer	answer is ministerial correction date of answer 21/02/2022 answer text <p>Up to £70 million of targeted funding under the National Health Service Cancer Programme’s Service Development Funding budget has been made available to support the running of Targeted Lung Health Checks (TLHC) in 2022/23. This will include the expansion of the programme to ensure a project in each Cancer Alliance.</p><p>NHS England and NHS Improvement also supports the delivery of the TLHC programme with standard protocols, expert advice, and nationally procured and coordinated quality assurance and training.</p><p>There are currently nine Cancer Alliances without a TLHC project. NHS England and NHS Improvement plan to expand the TLHC programme in 2022/23 to ensure that each of these Cancer Alliances has at least one TLHC programme. We estimate an additional eight computerised tomography (CT) scanners will be needed to facilitate this expansion.</p><p> </p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 121745 121746 question first answered 21/02/2022 09:10:42 answering member 4492 label Biography information for Maria Caulfield
tabling member	4092 label Biography information for Stephen Metcalfe

1402416

registered interest
date	12/01/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sodium Valproate
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what financial provision he has made to support the health needs of those affected by Sodium Valproate.
tabling member constituency	South Basildon and East Thurrock
tabling member printed	Stephen Metcalfe
uin	102614
answer	answer is ministerial correction date of answer 01/03/2022 answer text <p>Those affected by sodium valproate may be in receipt of Continuing Healthcare where individuals with long-term complex health needs qualify for free social care arranged and funded solely by the National Health Service. Personal Health Budgets are also available to support health and wellbeing needs, which is planned and agreed between the individual or their representative and the local clinical commissioning group.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 01/03/2022 12:56:43 answering member 4492 label Biography information for Maria Caulfield
tabling member	4092 label Biography information for Stephen Metcalfe